Macular Disease Foundation Australia today announced it has awarded more than $1 million to eight groundbreaking research projects as part of its 2025 funding round.
Macular Disease Foundation Australia (MDFA) has launched its new Research Impact Report, which showcases the groundbreaking projects our organisation has funded to help reduce the impact of macular disease.
Connecting with other people who are going through similar health experiences can improve how you manage your own condition.
Macular Disease Foundation Australia (MDFA) is committed to understanding the impact of macular disease on the lives and health of people who live with the condition. One of the ways we do this is through our Social Impact research.
Professor Chandra Balaratnasingam’s MDFA-funded research is exploring the cellular changes that occur in diabetic macular ischaemia (DMI) to help develop a breakthrough therapy.
Grant Family Fund support is allowing Dr Alexis Ceecee Britten-Jones to research a way to ensure people with rare inherited macular dystrophies receive the right treatment for them in future.
Find out how the Grant Family Fund is helping Dr Xavier Hadoux use cutting-edge technology to detect the early signs of macular disease.
A/Prof Gerald Liew’s second MDFA Research Grant is allowing him to investigate a potential sight-saving supplement to improve dysfunctional mitochondria and prevent age-related macular degeneration (AMD).
MDFA is Australia’s largest source of research funding in the field of macular disease outside of government.